Recommendations for presenting analyses of effect modification and interaction.

Authors often do not give sufficient information to draw conclusions about the size and statistical significance of interaction on the additive and multiplicative scales. To improve this, we provide four steps, template tables and examples. We distinguish two cases: when the causal effect of intervening on one exposure, across strata of another factor, is of interest ('effect modification'); and when the causal effect of intervening on two exposures is of interest ('interaction'). Assume we study whether X modifies the effect of A on D, where A, X and D are dichotomous. We propose presenting: (i) relative risks (RRs), odds ratios (ORs) or risk differences (RDs) for each (A, X) stratum with a single reference category taken as the stratum with the lowest risk of D; (ii) RRs, ORs or RDs for A within strata of X; (iii) interaction measures on additive and multiplicative scales; (iv) the A-D confounders adjusted for. Assume we study the interaction between A and B on D, where A, B and D are dichotomous. Steps (i) and (iii) are similar to presenting effect modification. (ii) Present RRs, ORs or RDs for A within strata of B and for B within strata of A. (iv) List the A-D and B-D confounders adjusted for. These four pieces of information will provide a reader the information needed to assess effect modification or interaction. The presentation can be further enriched when exposures have multiple categories. Our proposal hopefully encourages researchers to present effect modification and interaction analyses in as informative a manner as possible.

[1]  S. Vansteelandt,et al.  American Journal of Epidemiology Practice of Epidemiology a Weighting Approach to Causal Effects and Additive Interaction in Case-control Studies: Marginal Structural Linear Odds Models Discussion and Implications for Model Specification Table 1. Results for Simulation Comparing Marginal Structural , 2022 .

[2]  T. VanderWeele Causal Interactions in the Proportional Hazards Model , 2011, Epidemiology.

[3]  T. VanderWeele A word and that to which it once referred: assessing "biologic" interaction. , 2011, Epidemiology.

[4]  T. VanderWeele,et al.  Interpretation of Subgroup Analyses in Randomized Trials: Heterogeneity Versus Secondary Interventions , 2011, Annals of Internal Medicine.

[5]  Tyler J. VanderWeele,et al.  Estimating measures of interaction on an additive scale for preventive exposures , 2011, European Journal of Epidemiology.

[6]  A. Stang,et al.  Confidence intervals for the interaction contrast ratio. , 2010, Epidemiology.

[7]  T. VanderWeele On the Distinction Between Interaction and Effect Modification , 2009, Epidemiology.

[8]  T. VanderWeele,et al.  Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. , 2009, JAMA.

[9]  David B Richardson,et al.  American Journal of Epidemiology Practice of Epidemiology Estimation of the Relative Excess Risk Due to Interaction and Associated Confidence Bounds , 2022 .

[10]  Matthias Egger,et al.  When One Depends on the Other: Reporting of Interaction in Case-Control and Cohort Studies , 2009, Epidemiology.

[11]  Tyler J VanderWeele,et al.  Sufficient Cause Interactions and Statistical Interactions , 2009, Epidemiology.

[12]  J. Vandenbroucke,et al.  Practice of Epidemiology What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research , 2008 .

[13]  Guang Yong Zou,et al.  On the estimation of additive interaction by use of the four-by-two table and beyond. , 2008, American journal of epidemiology.

[14]  A. Egberts,et al.  No increased incidence of diabetes in antidepressant users , 2007, International clinical psychopharmacology.

[15]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Epidemiology.

[16]  D. Grobbee,et al.  Estimating interaction on an additive scale between continuous determinants in a logistic regression model. , 2007, International journal of epidemiology.

[17]  James M Robins,et al.  The Identification of Synergism in the Sufficient-Component-Cause Framework , 2007, Epidemiology.

[18]  L. Chambless,et al.  Test for additive interaction in proportional hazards models. , 2007, Annals of epidemiology.

[19]  Tomas Andersson,et al.  Calculating measures of biological interaction , 2005, European Journal of Epidemiology.

[20]  Anders Skrondal,et al.  Interaction as departure from additivity in case-control studies: a cautionary note. , 2003, American journal of epidemiology.

[21]  Jack A. Taylor,et al.  Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  K. Rothman Epidemiology: An Introduction , 2002 .

[23]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[24]  Theresa A. Singleton Commentary: Facing the challenges of a public African-American archaeology , 1997 .

[25]  F. Diderichsen,et al.  A SAS program calculating three measures of interaction with confidence intervals. , 1996, Epidemiology.

[26]  D. Hosmer,et al.  Confidence Intervals for Measures of Interaction , 1996, Epidemiology.

[27]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[28]  Kenneth Constantine,et al.  Confidence interval estimation of P(Y , 1990 .

[29]  D. G. Rees Confidence interval estimation , 1989 .

[30]  R. Saracci Interaction and synergism. , 1980, American journal of epidemiology.

[31]  S Greenland,et al.  Concepts of interaction. , 1980, American journal of epidemiology.

[32]  N. Day,et al.  Synergism and interaction: are they equivalent? , 1979, American journal of epidemiology.

[33]  M. Graffar [Modern epidemiology]. , 1971, Bruxelles medical.